Abstract
Dendritic cells (DCs) are pivotal regulators of immune responses, specialized in antigen presentation and bridging the gap between the innate and adaptive immune system. Due to these key features, DCs have become a pillar of the continuously growing field of cellular therapies. Here we review recent advances in good manufacturing practice strategies and their individual specificities in relation to DC production for clinical applications. These take into account both small-scale experimental approaches as well as automated systems for patient care.
References
1.
Starzl
TE
. History of clinical transplantation
. World J Surg
. 2000
Jul
;24
(7
):759
–82
.
[PubMed]
0364-23132.
Sadelain
M
, Brentjens
R
, Rivière
I
. The basic principles of chimeric antigen receptor design
. Cancer Discov
. 2013
Apr
;3
(4
):388
–98
.
[PubMed]
2159-82743.
Prieto
PA
, Durflinger
KH
, Wunderlich
JR
, Rosenberg
SA
, Dudley
ME
. Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy
. J Immunother
. 2010
Jun
;33
(5
):547
–56
.
[PubMed]
1524-95574.
Harzstark
AL
, Small
EJ
. Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge)
. Expert Opin Biol Ther
. 2007
Aug
;7
(8
):1275
–80
.
[PubMed]
1471-25985.
Merad
M
, Sathe
P
, Helft
J
, Miller
J
, Mortha
A
. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting
. Annu Rev Immunol
. 2013
;31
(1
):563
–604
.
[PubMed]
0732-05826.
Hemmi
H
, Akira
S
. “TLR Signalling and the Function of Dendritic Cells,” in Mechanisms of Epithelial Defense
. Volume 86
. Basel
: KARGER
; 2005
. pp. 120
–35
. 7.
Schlitzer
A
, McGovern
N
, Ginhoux
F
. Dendritic cells and monocyte-derived cells: two complementary and integrated functional systems
. Semin Cell Dev Biol
. 2015
May
;41
:9
–22
.
[PubMed]
1084-95218.
Joffre
OP
, Segura
E
, Savina
A
, Amigorena
S
. Cross-presentation by dendritic cells
. Nat Rev Immunol
. 2012
Jul
;12
(8
):557
–69
.
[PubMed]
1474-17339.
Collin
M
, Bigley
V
. Human dendritic cell subsets: an update
. Immunology
. 2018
May
;154
(1
):3
–20
.
[PubMed]
0019-280510.
P.
See
, et al., “Mapping the human DC lineage through the integration of high-dimensional techniques
,” Science (80-.) ., vol. 356, no. 6342, p. eaag3009, Jun.
2017
. 11.
Schlitzer
A
, Ginhoux
F
. Organization of the mouse and human DC network
. Curr Opin Immunol
. 2014
Feb
;26
(1
):90
–9
.
[PubMed]
0952-791512.
Baal
N
, Cunningham
S
, Obermann
HL
, Thomas
J
, Lippitsch
A
, Dietert
K
, et al. ADAR1 Is Required for Dendritic Cell Subset Homeostasis and Alveolar Macrophage Function
. J Immunol
. 2019
Feb
;202
(4
):1099
–111
.
[PubMed]
0022-176713.
Thurner
B
, Röder
C
, Dieckmann
D
, Heuer
M
, Kruse
M
, Glaser
A
, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
. J Immunol Methods
. 1999
Feb
;223
(1
):1
–15
.
[PubMed]
0022-175914.
Daenthanasanmak
A
, Salguero
G
, Sundarasetty
BS
, Waskow
C
, Cosgun
KN
, Guzman
CA
, et al. Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV
. Mol Ther Methods Clin Dev
. 2015
Jan
;1
(November
):14060
.
[PubMed]
2329-050115.
Harada
Y
, Okada-Nakanishi
Y
, Ueda
Y
, Tsujitani
S
, Saito
S
, Fuji-Ogawa
T
, et al. Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells
. Sci Rep
. 2011
;1
(1
):174
.
[PubMed]
2045-232216.
Coillard
A
, Segura
E
. In vivo Differentiation of Human Monocytes
. Front Immunol
. 2019
Aug
;10
(August
):1907
.
[PubMed]
1664-322417.
Schlitzer
A
, Sivakamasundari
V
, Chen
J
, Sumatoh
HR
, Schreuder
J
, Lum
J
, et al. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow
. Nat Immunol
. 2015
Jul
;16
(7
):718
–28
.
[PubMed]
1529-290818.
Shi
Y
, Liu
CH
, Roberts
AI
, Das
J
, Xu
G
, Ren
G
, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don’t know
. Cell Res
. 2006
Feb
;16
(2
):126
–33
.
[PubMed]
1001-060219.
Kuhn
S
, Ronchese
F
. Monocyte-derived dendritic cells: emerging players in the antitumor immune response
. OncoImmunology
. 2013
Nov
;2
(11
):e26443
.
[PubMed]
2162-401120.
Zhu
K
, Shen
Q
, Ulrich
M
, Zheng
M
. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines
. Chin Med J (Engl)
. 2000
Dec
;113
(12
):1124
–8
.
[PubMed]
0366-699921.
Schinnerling
K
, García-González
P
, Aguillón
JC
. Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of Tolerogenicity
. Front Immunol
. 2015
Oct
;6
(OCT
):528
.
[PubMed]
1664-322422.
Steinbrink
K
, Wölfl
M
, Jonuleit
H
, Knop
J
, Enk
AH
. Induction of tolerance by IL-10-treated dendritic cells
. J Immunol
. 1997
Nov
;159
(10
):4772
–80
.
[PubMed]
0022-176723.
Fogel-Petrovic
M
, Long
JA
, Misso
NL
, Foster
PS
, Bhoola
KD
, Thompson
PJ
. Physiological concentrations of transforming growth factor β1 selectively inhibit human dendritic cell function
. Int Immunopharmacol
. 2007
Dec
;7
(14
):1924
–33
.
[PubMed]
1567-576924.
Xia
CQ
, Peng
R
, Beato
F
, Clare-Salzler
MJ
. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity
. Scand J Immunol
. 2005
Jul
;62
(1
):45
–54
.
[PubMed]
0300-947525.
Fedoric
B
, Krishnan
R
. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction
. Immunol Lett
. 2008
Oct
;120
(1-2
):49
–56
.
[PubMed]
0165-247826.
Rogers
NM
, Kireta
S
, Coates
PT
. Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo
. Clin Exp Immunol
. 2010
Dec
;162
(3
):460
–73
.
[PubMed]
0009-910427.
Zapata-Gonzalez
F
, Rueda
F
, Petriz
J
, Domingo
P
, Villarroya
F
, de Madariaga
A
, et al. 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor γ blocks some of the 9cRA activities, and precludes them to mature phenotype development
. J Immunol
. 2007
May
;178
(10
):6130
–9
.
[PubMed]
0022-176728.
Hilkens
CM
, Isaacs
JD
. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
Clin Exp Immunol
. 2013
May
;172
(2
):148
–57
.
[PubMed]
0009-910429.
Steinbrink
K
, Graulich
E
, Kubsch
S
, Knop
J
, Enk
AH
. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity
. Blood
. 2002
Apr
;99
(7
):2468
–76
.
[PubMed]
0006-497130.
Willekens
B
, Presas-Rodríguez
S
, Mansilla
MJ
, Derdelinckx
J
, Lee
WP
, Nijs
G
, et al.; RESTORE consortium
. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
. BMJ Open
. 2019
Sep
;9
(9
):e030309
.
[PubMed]
2044-605531.
Morelli
AE
, Thomson
AW
. Tolerogenic dendritic cells and the quest for transplant tolerance
. Nat Rev Immunol
. 2007
Aug
;7
(8
):610
–21
.
[PubMed]
1474-173332.
Hopewell
EL
, Cox
C
. Manufacturing Dendritic Cells for Immunotherapy: monocyte Enrichment
. Mol Ther Methods Clin Dev
. 2020
Jan
;16
(March
):155
–60
.
[PubMed]
2329-050133.
Berger
TG
, Strasser
E
, Smith
R
, Carste
C
, Schuler-Thurner
B
, Kaempgen
E
, et al. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells
. J Immunol Methods
. 2005
Mar
;298
(1-2
):61
–72
.
[PubMed]
0022-175934.
de Almeida
MC
, Silva
AC
, Barral
A
, Barral Netto
M
. A simple method for human peripheral blood monocyte isolation
. Mem Inst Oswaldo Cruz
. 2000
Mar-Apr
;95
(2
):221
–3
.
[PubMed]
0074-027635.
Delirezh
N
, Shojaeefar
E
, Parvin
P
, Asadi
B
. Comparison the effects of two monocyte isolation methods, plastic adherence and magnetic activated cell sorting methods, on phagocytic activity of generated dendritic cells
. Cell J
. 2013
;15
(3
):218
–23
.
[PubMed]
2228-580636.
Felzmann
T
, Witt
V
, Wimmer
D
, Ressmann
G
, Wagner
D
, Paul
P
, et al. Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection
. Cytotherapy
. 2003
;5
(5
):391
–8
.
[PubMed]
1465-324937.
Patarroyo
M
, Prieto
J
, Beatty
PG
, Clark
EA
, Gahmberg
CG
. Adhesion-mediating molecules of human monocytes
. Cell Immunol
. 1988
May
;113
(2
):278
–89
.
[PubMed]
0008-874938.
Janssen
WE
, Ribickas
A
, Meyer
LV
, Smilee
RC
. Large-scale Ficoll gradient separations using a commercially available, effectively closed, system
. Cytotherapy
. 2010
May
;12
(3
):418
–24
.
[PubMed]
1465-324939.
Law
P
, Dooley
DC
, Alsop
P
, Smith
DM
, Landmark
JD
, Meryman
HT
. Density gradient isolation of peripheral blood mononuclear cells using a blood cell processor
. Transfusion
. 1988
Mar-Apr
;28
(2
):145
–50
.
[PubMed]
0041-113240.
Faradji
A
, Bohbot
A
, Schmitt-Goguel
M
, Siffert
JC
, Dumont
S
, Wiesel
ML
, et al. Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients
. J Immunol Methods
. 1994
Sep
;174
(1-2
):297
–309
.
[PubMed]
0022-175941.
Morijiri
T
, Yamada
M
, Hikida
T
, Seki
M
. Microfluidic counterflow centrifugal elutriation system for sedimentation-based cell separation
. Microfluid Nanofluidics
. 2013
Jun
;14
(6
):1049
–57
. 1613-498242.
Strasser
EF
, Eckstein
R
. Optimization of leukocyte collection and monocyte isolation for dendritic cell culture
. Transfus Med Rev
. 2010
Apr
;24
(2
):130
–9
.
[PubMed]
0887-796343.
Stroncek
DF
, Fellowes
V
, Pham
C
, Khuu
H
, Fowler
DH
, Wood
LV
, et al. Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies
. J Transl Med
. 2014
Sep
;12
(1
):241
.
[PubMed]
1479-587644.
Jarnjak-Jankovic
S
, Hammerstad
H
, Saebøe-Larssen
S
, Kvalheim
G
, Gaudernack
G
. A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
. BMC Cancer
. 2007
Jul
;7
(1
):119
.
[PubMed]
1471-240745.
Bauer
J
. Advances in cell separation: recent developments in counterflow centrifugal elutriation and continuous flow cell separation
. J Chromatogr B Biomed Sci Appl
. 1999
Feb
;722
(1-2
):55
–69
.
[PubMed]
1387-227346.
Eyrich
M
, Schreiber
SC
, Rachor
J
, Krauss
J
, Pauwels
F
, Hain
J
, et al. Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells
. Cytotherapy
. 2014
Jul
;16
(7
):946
–64
.
[PubMed]
1465-324947.
Boudousquié
C
, Boand
V
, Lingre
E
, Dutoit
L
, Balint
K
, Danilo
M
, et al. Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
. Vaccines (Basel)
. 2020
Jan
;8
(1
):25
.
[PubMed]
2076-393X48.
Wu
Z
, Zhang
Z
, Lei
Z
, Lei
P
. CD14: biology and role in the pathogenesis of disease
. Cytokine Growth Factor Rev
. 2019
Aug
;48
:24
–31
.
[PubMed]
1359-610149.
Elkord
E
, Williams
PE
, Kynaston
H
, Rowbottom
AW
. Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells
. Immunology
. 2005
Feb
;114
(2
):204
–12
.
[PubMed]
0019-280550.
Kalinski
P
, Muthuswamy
R
, Urban
J
. Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
. Expert Rev Vaccines
. 2013
Mar
;12
(3
):285
–95
.
[PubMed]
1476-058451.
Knutson
KL
, Disis
ML
. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
. Cancer Immunol Immunother
. 2005
Aug
;54
(8
):721
–8
.
[PubMed]
0340-700452.
Liu
JM
, Zhu
Y
, Xu
ZW
, Ouyang
WM
, Wang
JP
, Liu
XS
, et al. Dynamic changes of apoptosis-inducing ligands and Th1/Th2 like subpopulations in Hantaan virus-induced hemorrhagic fever with renal syndrome
. Clin Immunol
. 2006
Jun
;119
(3
):245
–51
.
[PubMed]
1521-661653.
Fang
Y
, Yu
S
, Ellis
JS
, Sharav
T
, Braley-Mullen
H
. Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis
. J Leukoc Biol
. 2010
Jun
;87
(6
):1019
–28
.
[PubMed]
0741-540054.
Meng
Y
, Sun
J
, Hu
T
, Ma
Y
, Du
T
, Kong
C
, et al. Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy
. Hum Vaccin Immunother
. 2018
;14
(10
):2516
–26
.
[PubMed]
2164-551555.
Uslu
U
, Erdmann
M
, Wiesinger
M
, Schuler
G
, Schuler-Thurner
B
. Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines
. Cytotherapy
. 2019
Nov
;21
(11
):1166
–78
.
[PubMed]
1465-324956.
Startz
T
, Nguyen
K
, Peters
R
, Nankervis
B
, Jones
M
, Kilian
R
, et al. Maturation of dendritic cells from CD14+ monocytes in an automated functionally closed hollow fiber bioreactor system
. Cytotherapy
. 2014
Apr
;16
(4
):S29
. 1465-324957.
Erdmann
M
, Uslu
U
, Wiesinger
M
, Brüning
M
, Altmann
T
, Strasser
E
, et al. Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy
. J Immunol Methods
. 2018
Dec
;463
(September
):89
–96
.
[PubMed]
0022-175958.
Fekete
N
, Béland
AV
, Campbell
K
, Clark
SL
, Hoesli
CA
. Bags versus flasks: a comparison of cell culture systems for the production of dendritic cell-based immunotherapies
. Transfusion
. 2018
Jul
;58
(7
):1800
–13
.
[PubMed]
0041-113259.
Guyre
CA
, Fisher
JL
, Waugh
MG
, Wallace
PK
, Tretter
CG
, Ernstoff
MS
, et al. Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications
. J Immunol Methods
. 2002
Apr
;262
(1-2
):85
–94
.
[PubMed]
0022-175960.
Markowicz
S
, Engleman
EG
. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro
. J Clin Invest
. 1990
Mar
;85
(3
):955
–61
.
[PubMed]
0021-973861.
K. C.
Roy
, G.
Bandyopadhyay
, S.
Rakshit
, M.
Ray
, and S.
Bandyopadhyay
, “IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1a(dim), CD83(+) myeloid dendritic cell subset.
,” J. Cell Sci., vol. 117, no. Pt 16, pp. 3435–45, Jul.
2004
.62.
Relloso
M
, Puig-Kröger
A
, Pello
OM
, Rodríguez-Fernández
JL
, de la Rosa
G
, Longo
N
, et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-β, and anti-inflammatory agents
. J Immunol
. 2002
Mar
;168
(6
):2634
–43
.
[PubMed]
0022-176763.
Vopenkova
K
, Mollova
K
, Buresova
I
, Michalek
J
. Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy
. J Cell Mol Med
. 2012
Nov
;16
(11
):2827
–37
.
[PubMed]
1582-183864.
Nair
S
, Archer
GE
, Tedder
TF
. Isolation and generation of human dendritic cells
. Curr Protoc Immunol
. 2012
Nov
;Chapter 7
(1
):32
.
[PubMed]
1934-367165.
Schnurr
M
, Galambos
P
, Scholz
C
, Then
F
, Dauer
M
, Endres
S
, et al. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines
. Cancer Res
. 2001
Sep
;61
(17
):6445
–50
.
[PubMed]
0008-547266.
Dauer
M
, Obermaier
B
, Herten
J
, Haerle
C
, Pohl
K
, Rothenfusser
S
, et al. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors
. J Immunol
. 2003
Apr
;170
(8
):4069
–76
.
[PubMed]
0022-176767.
Le Naour
F
, Hohenkirk
L
, Grolleau
A
, Misek
DE
, Lescure
P
, Geiger
JD
, et al. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics
. J Biol Chem
. 2001
May
;276
(21
):17920
–31
.
[PubMed]
0021-925868.
Angénieux
C
, Fricker
D
, Strub
JM
, Luche
S
, Bausinger
H
, Cazenave
JP
, et al. Gene induction during differentiation of human monocytes into dendritic cells: an integrated study at the RNA and protein levels
. Funct Integr Genomics
. 2001
Sep
;1
(5
):323
–9
.
[PubMed]
1438-793X69.
McGreal
EP
, Miller
JL
, Gordon
S
. Ligand recognition by antigen-presenting cell C-type lectin receptors
. Curr Opin Immunol
. 2005
Feb
;17
(1
):18
–24
.
[PubMed]
0952-791570.
Engering
A
, Geijtenbeek
TB
, van Vliet
SJ
, Wijers
M
, van Liempt
E
, Demaurex
N
, et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells
. J Immunol
. 2002
Mar
;168
(5
):2118
–26
.
[PubMed]
0022-176771.
Hosszu
KK
, Valentino
A
, Vinayagasundaram
U
, Vinayagasundaram
R
, Joyce
MG
, Ji
Y
, et al. DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells
. Blood
. 2012
Aug
;120
(6
):1228
–36
.
[PubMed]
0006-497172.
Monrad
SU
, Rea
K
, Thacker
S
, Kaplan
MJ
. Myeloid dendritic cells display downregulation of C-type lectin receptors and aberrant lectin uptake in systemic lupus erythematosus
. Arthritis Res Ther
. 2008
;10
(5
):R114
.
[PubMed]
1478-635473.
Zobywalski
A
, Javorovic
M
, Frankenberger
B
, Pohla
H
, Kremmer
E
, Bigalke
I
, et al. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70
. J Transl Med
. 2007
Apr
;5
(1
):18
.
[PubMed]
1479-587674.
Massa
C
, Thomas
C
, Wang
E
, Marincola
F
, Seliger
B
. Different maturation cocktails provide dendritic cells with different chemoattractive properties
. J Transl Med
. 2015
Jun
;13
(1
):175
.
[PubMed]
1479-587675.
Castiello
L
, Sabatino
M
, Jin
P
, Clayberger
C
, Marincola
FM
, Krensky
AM
, et al. Monocyte-derived DC maturation strategies and related pathways: a transcriptional view
. Cancer Immunol Immunother
. 2011
Apr
;60
(4
):457
–66
.
[PubMed]
0340-700476.
Appay
V
, Rowland-Jones
SL
. RANTES: a versatile and controversial chemokine
. Trends Immunol
. 2001
Feb
;22
(2
):83
–7
.
[PubMed]
1471-490677.
Hu
X
, Yee
E
, Harlan
JM
, Wong
F
, Karsan
A
. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells
. Blood
. 1998
Oct
;92
(8
):2759
–65
.
[PubMed]
0006-497178.
Chen
P
, Li
J
, Barnes
J
, Kokkonen
GC
, Lee
JC
, Liu
Y
. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages
. J Immunol
. 2002
Dec
;169
(11
):6408
–16
.
[PubMed]
0022-176779.
Messmer
D
, Messmer
B
, Chiorazzi
N
. The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells
. Int Immunol
. 2003
Apr
;15
(4
):491
–503
.
[PubMed]
0953-817880.
Korthals
M
, Safaian
N
, Kronenwett
R
, Maihöfer
D
, Schott
M
, Papewalis
C
, et al. Monocyte derived dendritic cells generated by IFN-α acquire mature dendritic and natural killer cell properties as shown by gene expression analysis
. J Transl Med
. 2007
Sep
;5
(1
):46
.
[PubMed]
1479-587681.
Matsunaga
T
, Ishida
T
, Takekawa
M
, Nishimura
S
, Adachi
M
, Imai
K
. Analysis of gene expression during maturation of immature dendritic cells derived from peripheral blood monocytes
. Scand J Immunol
. 2002
Dec
;56
(6
):593
–601
.
[PubMed]
0300-947582.
Schlaak
JF
, Hilkens
CM
, Costa-Pereira
AP
, Strobl
B
, Aberger
F
, Frischauf
AM
, et al. Cell-type and donor-specific transcriptional responses to interferon-α. Use of customized gene arrays
. J Biol Chem
. 2002
Dec
;277
(51
):49428
–37
.
[PubMed]
0021-925883.
Longhi
MP
, Trumpfheller
C
, Idoyaga
J
, Caskey
M
, Matos
I
, Kluger
C
, et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
. J Exp Med
. 2009
Jul
;206
(7
):1589
–602
.
[PubMed]
0022-100784.
Möller
I
, Michel
K
, Frech
N
, Burger
M
, Pfeifer
D
, Frommolt
P
, et al. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application
. J Immunother
. 2008
Jun
;31
(5
):506
–19
.
[PubMed]
1524-955785.
Kaliński
P
, Vieira
PL
, Schuitemaker
JH
, de Jong
EC
, Kapsenberg
ML
. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer
. Blood
. 2001
Jun
;97
(11
):3466
–9
.
[PubMed]
0006-497186.
Luft
T
, Jefford
M
, Luetjens
P
, Toy
T
, Hochrein
H
, Masterman
KA
, et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets
. Blood
. 2002
Aug
;100
(4
):1362
–72
.
[PubMed]
0006-497187.
Morelli
AE
, Thomson
AW
. Dendritic cells under the spell of prostaglandins
. Trends Immunol
. 2003
Mar
;24
(3
):108
–11
.
[PubMed]
1471-490688.
Dauer
M
, Lam
V
, Arnold
H
, Junkmann
J
, Kiefl
R
, Bauer
C
, et al. Combined use of toll-like receptor agonists and prostaglandin E(2) in the FastDC model: rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production
. J Immunol Methods
. 2008
Sep
;337
(2
):97
–105
.
[PubMed]
0022-175989.
Jin
P
, Han
TH
, Ren
J
, Saunders
S
, Wang
E
, Marincola
FM
, et al. Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies
. J Transl Med
. 2010
Jan
;8
(1
):4
.
[PubMed]
1479-587690.
Mastelic-Gavillet
B
, Balint
K
, Boudousquie
C
, Gannon
PO
, Kandalaft
LE
. Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results
. Front Immunol
. 2019
Apr
;10
(APR
):766
.
[PubMed]
1664-322491.
Schuler
PJ
, Harasymczuk
M
, Visus
C
, Deleo
A
, Trivedi
S
, Lei
Y
, et al. Phase I dendritic cell p53 peptide vaccine for head and neck cancer
. Clin Cancer Res
. 2014
May
;20
(9
):2433
–44
.
[PubMed]
1078-043292.
Di Pucchio
T
, Pilla
L
, Capone
I
, Ferrantini
M
, Montefiore
E
, Urbani
F
, et al. Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-α results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors
. Cancer Res
. 2006
May
;66
(9
):4943
–51
.
[PubMed]
0008-547293.
Copier
J
, Dalgleish
A
. Overview of tumor cell-based vaccines
. Int Rev Immunol
. 2006
Sep-Dec
;25
(5-6
):297
–319
.
[PubMed]
0883-018594.
Kim
JH
, Lee
Y
, Bae
YS
, Kim
WS
, Kim
K
, Im
HY
, et al. Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma
. Clin Immunol
. 2007
Dec
;125
(3
):257
–67
.
[PubMed]
1521-661695.
Hobo
W
, Maas
F
, Adisty
N
, de Witte
T
, Schaap
N
, van der Voort
R
, et al. siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells
. Blood
. 2010
Nov
;116
(22
):4501
–11
.
[PubMed]
0006-497196.
Knippertz
I
, Hesse
A
, Schunder
T
, Kämpgen
E
, Brenner
MK
, Schuler
G
, et al. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-γ
. J Immunother
. 2009
Jun
;32
(5
):524
–38
.
[PubMed]
1524-955797.
Koya
RC
, Kasahara
N
, Favaro
PM
, Lau
R
, Ta
HQ
, Weber
JS
, et al. Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery
. J Immunother
. 2003
Sep-Oct
;26
(5
):451
–60
.
[PubMed]
1524-955798.
Wilgenhof
S
, Corthals
J
, Heirman
C
, van Baren
N
, Lucas
S
, Kvistborg
P
, et al. Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
. J Clin Oncol
. 2016
Apr
;34
(12
):1330
–8
.
[PubMed]
0732-183X99.
Squadrito
ML
, Cianciaruso
C
, Hansen
SK
, De Palma
M
. EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens
. Nat Methods
. 2018
Mar
;15
(3
):183
–6
.
[PubMed]
1548-7091100.
Perez
CR
, De Palma
M
. Engineering dendritic cell vaccines to improve cancer immunotherapy
. Nat Commun
. 2019
Nov
;10
(1
):5408
.
[PubMed]
2041-1723101.
Sundarasetty
BS
, Kloess
S
, Oberschmidt
O
, Naundorf
S
, Kuehlcke
K
, Daenthanasanmak
A
, et al. Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation
. J Transl Med
. 2015
Jul
;13
(1
):240
.
[PubMed]
1479-5876102.
Daenthanasanmak
A
, Salguero
G
, Borchers
S
, Figueiredo
C
, Jacobs
R
, Sundarasetty
BS
, et al. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo
. Vaccine
. 2012
Jul
;30
(34
):5118
–31
.
[PubMed]
0264-410X103.
Bialek-Waldmann
JK
, Heuser
M
, Ganser
A
, Stripecke
R
. Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation
. Cancer Immunol Immunother
. 2019
Nov
;68
(11
):1891
–9
.
[PubMed]
0340-7004104.
Salguero
G
, Daenthanasanmak
A
, Münz
C
, Raykova
A
, Guzmán
CA
, Riese
P
, et al. Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation
. J Immunol
. 2014
May
;192
(10
):4636
–47
.
[PubMed]
0022-1767105.
Liau
LM
, Ashkan
K
, Tran
DD
, Campian
JL
, Trusheim
JE
, Cobbs
CS
, et al. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
. J Transl Med
. 2018
May
;16
(1
):142
.
[PubMed]
1479-5876© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.